Impact of azithromycin and nitazoxanide on the enteric infections and child growth: Findings from the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) trial.
Godfrey GugaEric R HouptSarah ElwoodJie LiuCaroline KimathiRestituta MoshaMariam TemuAthanasia MaroBuliga MujagaNdealilia SwaiSuporn PholwatElizabeth T R McQuadeEsto R MdumaMark D DeBoerJames Platts-MillsPublished in: PloS one (2023)
The antimicrobial intervention of quarterly azithromycin plus or minus nitazoxanide led to only transient decreases in enteric infections with Shigella/EIEC, enteroaggregative E. coli (EAEC), Campylobacter, and Giardia. There was a trend towards improved growth in children infected with Campylobacter that received quarterly azithromycin.